NGL Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs LRN Q1 2026 Earnings EPS Beat Drives Positive Momentum Despite Revenue Uncertainty BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rise 358 KHC Q1 2026 Earnings EPS Surges Past Estimates Amid Cost Discipline Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline